| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yufei Wang, Qusang Danzeng, Wencan Jiang, Bingqing Han, Xiaowen Zhu, Ziwei Liu, Jialu Sun, Kelin Chen, Guojun Zhan. A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective. Frontiers in neurology. vol 14. 2023-09-29. PMID:37771453. |
to analyze the differences in laboratory data between patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2023-09-29 |
2023-10-07 |
Not clear |
| Yan Wu, Ruth Geraldes, Maciej Juryńczyk, Jacqueline Palac. Double-negative neuromyelitis optica spectrum disorder. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-09-23. PMID:37740717. |
most patients with neuromyelitis optica spectrum disorders (nmosd) test positive for aquaporin-4 antibody (aqp4-igg) or myelin oligodendrocyte glycoprotein antibodies (mog-igg). |
2023-09-23 |
2023-10-07 |
Not clear |
| Kshiteeja Jain, M Anita, M Netravath. Double hit - A case in point for dual seropositivity to AQP4 and MOG antibodies. Journal of neuroimmunology. vol 383. 2023-09-16. PMID:37716133. |
aqp4-igg nmosd (anti-aquaporin-4 neuromyelitis optica spectrum disorder) and mogad (myelin oligodendrocyte glycoprotein antibody associated disease) are unique disorders among themselves, with rare reports of dual seropositivity being described. |
2023-09-16 |
2023-10-07 |
Not clear |
| Ryuji Sakakibar. Gastrointestinal Dysfunction in Multiple Sclerosis and Related Conditions. Seminars in neurology. vol 43. issue 4. 2023-09-13. PMID:37703888. |
this review addresses gi dysfunction caused by multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein-associated disorder. |
2023-09-13 |
2023-10-07 |
Not clear |
| Majid Moshirfar, Duncan J Williams, Melody Ziari, Meagan D Seay, Yasmyne C Ronquill. Laser-Assisted In Situ Keratomileusis Surgery on a Patient with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease or Neuromyelitis Optica Spectrum Disorder. Case reports in ophthalmological medicine. vol 2023. 2023-09-04. PMID:37663590. |
laser-assisted in situ keratomileusis surgery on a patient with myelin oligodendrocyte glycoprotein antibody-associated disease or neuromyelitis optica spectrum disorder. |
2023-09-04 |
2023-09-07 |
Not clear |
| Majid Moshirfar, Duncan J Williams, Melody Ziari, Meagan D Seay, Yasmyne C Ronquill. Laser-Assisted In Situ Keratomileusis Surgery on a Patient with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease or Neuromyelitis Optica Spectrum Disorder. Case reports in ophthalmological medicine. vol 2023. 2023-09-04. PMID:37663590. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and neuromyelitis optica spectrum disorder (nmosd) are rare central demyelinating diseases that may affect refractive surgery outcomes. |
2023-09-04 |
2023-09-07 |
Not clear |
| Mengyu Wang, Dongxia Xia, Lin Sun, Jianzhong Bi, Keqin Xie, Pin Wan. Interleukin-33 as a Biomarker Affecting Intrathecal Synthesis of Immunoglobulin in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. European neurology. vol 86. issue 4. 2023-09-03. PMID:37100033. |
interleukin-33 as a biomarker affecting intrathecal synthesis of immunoglobulin in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-09-03 |
2023-09-07 |
Not clear |
| Jeff Huang, Donald Brien, Brian C Coe, Giulia Longoni, Donald J Mabbott, Douglas P Munoz, E Ann Ye. Delayed oculomotor response associates with optic neuritis in youth with demyelinating disorders. Multiple sclerosis and related disorders. vol 79. 2023-09-03. PMID:37660456. |
impairment in visual and cognitive functions occur in youth with demyelinating disorders such as multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-09-03 |
2023-09-07 |
Not clear |
| Carles Gaig, Francesc Grau. Motor symptoms in nonparaneoplastic CNS disorders associated with neural antibodies. Handbook of clinical neurology. vol 196. 2023-08-24. PMID:37620074. |
two present motor symptoms mainly due to the involvement of the spinal cord: neuromyelitis optica spectrum disorders with aquaporin-4 antibodies and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-08-24 |
2023-09-07 |
Not clear |
| Fatin Aylia, Karn Johri, Riley Spencer, David Chu, Mehron Deriss, Davin Peng, Jonathan Eskenazi, Antonio K Li. A Patient With Miller Fisher Syndrome With Positive GQ1b and Aquaporin-4 Antibodies: Will There Be an Aquaporin-4 Antibody Associated Disorder? Cureus. vol 15. issue 8. 2023-08-15. PMID:37581199. |
there have been many advancements in the field of neuromyelitis optica and neuromyelitis optica spectrum disorder since the discovery of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein antibodies. |
2023-08-15 |
2023-09-07 |
Not clear |
| Fatin Aylia, Karn Johri, Riley Spencer, David Chu, Mehron Deriss, Davin Peng, Jonathan Eskenazi, Antonio K Li. A Patient With Miller Fisher Syndrome With Positive GQ1b and Aquaporin-4 Antibodies: Will There Be an Aquaporin-4 Antibody Associated Disorder? Cureus. vol 15. issue 8. 2023-08-15. PMID:37581199. |
it is also recognized that the pathological features associated with myelin oligodendrocyte glycoprotein antibodies are beyond the domain of neuromyelitis optica spectrum disorder and there is a separate nomenclature, namely myelin oligodendrocyte glycoprotein antibody associated disease. |
2023-08-15 |
2023-09-07 |
Not clear |
| Fatin Aylia, Karn Johri, Riley Spencer, David Chu, Mehron Deriss, Davin Peng, Jonathan Eskenazi, Antonio K Li. A Patient With Miller Fisher Syndrome With Positive GQ1b and Aquaporin-4 Antibodies: Will There Be an Aquaporin-4 Antibody Associated Disorder? Cureus. vol 15. issue 8. 2023-08-15. PMID:37581199. |
we report on a patient with mfs that was positive for gq1b and aquaporin-4 antibodies but negative for myelin oligodendrocyte glycoprotein antibodies and is devoid of any features of neuromyelitis optica spectrum disorder. |
2023-08-15 |
2023-09-07 |
Not clear |
| D D Eliseeva, A K Kalashnikova, V V Bryukhov, N A Andreeva, N V Zhorzholadze, Yu K Murakhovskaya, T D Krilova, P G Tsygankova, M N Zakharova, N L Shereme. [Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. Vyp. 2. 2023-08-10. PMID:37560844. |
optic neuritis can occur at the onset or be one of the syndromes within multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad). |
2023-08-10 |
2023-08-16 |
Not clear |
| João Vitor Gerdulli Tamanini, João Vitor Sabino, Rafael Alves Cordeiro, Vanessa Mizubuti, Luciano de Lima Villarinho, Juliana Ávila Duarte, Fernanda Veloso Pereira, Simone Appenzeller, Alfredo Damasceno, Fabiano Rei. The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies. Seminars in ultrasound, CT, and MR. 2023-08-09. PMID:37555683. |
the main imaging patterns of demyelinating myelopathies (multiple sclerosis, neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, and myelin oligodendrocyte glycoprotein antibody-related disorder) and inflammatory myelopathies (systemic lupus erythematosus-myelitis, sarcoidosis-myelitis, sjögren-myelitis, and behçet's-myelitis) will be discussed in this article, highlighting key points to the differential diagnosis. |
2023-08-09 |
2023-08-16 |
Not clear |
| Yoshiki Takai, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Frontiers in neurology. vol 14. 2023-08-07. PMID:37545724. |
pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. |
2023-08-07 |
2023-08-14 |
human |
| Jessica A Kraker, John J Che. An update on optic neuritis. Journal of neurology. 2023-08-05. PMID:37542657. |
although most cases of optic neuritis (on) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (aqp4)-igg neuromyelitis optica spectrum disorder (nmosd) and the recently described entity, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-08-05 |
2023-08-14 |
Not clear |
| David Berhanu, Miguel Leal Rato, Silvia Messina, Maria Isabel Leite, Ruth Geraldes, Jacqueline Palac. The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-08-02. PMID:37528605. |
the effect of smoking on the resolution of magnetic resonance imaging (mri) lesions in patients with neuromyelitis optica spectrum disorders with aquaporin-4 positive antibody (nmosd-aqp4) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) has not been studied before. |
2023-08-02 |
2023-08-14 |
Not clear |
| Grace Gombolay, Jamika Hallman-Coope. COVID-19 and the Pandemic-Related Aspects in Pediatric Demyelinating Disorders. Seminars in pediatric neurology. vol 46. 2023-07-14. PMID:37451752. |
cases of myelin oligodendrocyte glycoprotein antibody disease, neuromyelitis optica spectrum disorder, and multiple sclerosis are also described. |
2023-07-14 |
2023-08-14 |
Not clear |
| Jana Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy, Robert Hoepner, Christopher Linington, Andrew Chan, Jeffrey L Bennett, Volker Enzmann, Anke Salme. Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 5. 2023-07-10. PMID:37429715. |
mechanisms of visual impairment in aquaporin 4 antibody (aqp4-igg) seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody (mog-igg)-associated disorder (mogad) are incompletely understood. |
2023-07-10 |
2023-08-14 |
Not clear |
| Qiao Xu, Xixi Yang, Zhandong Qiu, Dawei Li, Hongxing Wang, Hong Ye, Lidong Jiao, Jing Zhang, Li Di, Peng Lei, Huiqing Dong, Zheng Li. Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS. Multiple sclerosis and related disorders. vol 77. 2023-07-04. PMID:37402345. |
clinical features of mogad with brainstem involvement in the initial attack versus nmosd and ms. to assess the characteristics of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) with brainstem involvement in the first event (bsife) and make comparisons with aquaporin-4-igg seropositive neuromyelitis optica spectrum disorder (aqp4-igg-nmosd) and multiple sclerosis (ms). |
2023-07-04 |
2023-08-14 |
Not clear |